Kattie Duplessis
Psychiatric/Mental Health · Houma, LANPI 1396500211
Payments from drug & device makers
Across 168 payments — averaging $19.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$439
- Neurocrine Biosciences, Inc.$437
- AbbVie$371
- Vanda Pharmaceuticals Inc.$301
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$253
- Johnson & Johnson$239
- plus $1K from 13 others
What the payments were for
- Food & beverage$3,13497%
- Education$1113%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 30 | $439 |
| Neurocrine Biosciences, Inc. | 22 | $437 |
| AbbVie | 19 | $371 |
| Vanda Pharmaceuticals Inc. | 11 | $301 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $253 |
| Johnson & Johnson | 11 | $239 |
| Teva Pharmaceuticals USA, Inc. | 7 | $228 |
| E.r. Squibb & Sons, L.L.C. | 15 | $210 |
| Otsuka America Pharmaceutical, Inc. | 11 | $187 |
| Merck | 8 | $167 |
| Axsome Therapeutics, Inc. | 7 | $148 |
| Corium, LLC | 7 | $88 |
| Indivior Inc. | 2 | $57 |
| Biocryst US Sales Co., LLC | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
| Viiv Healthcare Company | 1 | $21 |
| Ironshore Pharmaceuticals Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $18 |
| Braeburn Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$105
How this compares
$3,246 in reported general payments places this provider in the 75th percentile of 615 psychiatric/mental health providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Venlafaxine Hcl ErVenlafaxine Hcl | 22 | $2,093 |
| Oxcarbazepine | 21 | $821 |
| Lurasidone Hcl | 20 | $466 |
| Hydroxyzine Hcl | 22 | $362 |
| Quetiapine Fumarate | 36 | $309 |
| Buspirone Hcl | 24 | $280 |
| Olanzapine | 19 | $277 |
| Trazodone Hcl | 49 | $229 |
| Aripiprazole | 11 | $188 |
| Prazosin Hcl | 14 | $151 |
| Escitalopram Oxalate | 16 | $115 |
| Bupropion XlBupropion Hcl | 12 | $107 |
| Clonazepam | 12 | $105 |
| Sertraline Hcl | 27 | $78 |
| Fluoxetine Hcl | 15 | $43 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Houma
- Amanda EymardHouma$617K
- Timothy PellegrinHouma$210K
- Harry BrownHouma$9K
- Amy LacoutureBaton Rouge$663K
- Amber LittlefieldBroussard$225K
- Melissa GuilbeauLafayette$122K
- Kimberly ForcinelShreveport$92K
- Sattaria DilksLake Charles$57K
- Joe TaylorHammond$38K
- Lecy AlbaradoScott$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.